Published in Crit Care Med on July 01, 2008
Sepsis biomarkers: a review. Crit Care (2010) 4.76
New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev (2012) 2.01
Biomarkers of sepsis. Crit Rev Clin Lab Sci (2013) 1.48
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care (2014) 1.26
Role of biomarkers in sepsis care. Shock (2013) 1.19
Rapid diagnosis of sepsis. Virulence (2013) 1.06
Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One (2009) 0.98
Biomarkers for sepsis: a review with special attention to India. Biomed Res Int (2014) 0.97
Biomarkers of sepsis. Infect Chemother (2014) 0.95
Lipopolysaccharide-binding protein for monitoring of postoperative sepsis: complemental to C-reactive protein or redundant? PLoS One (2011) 0.92
Granulocyte colony stimulating factor induces lipopolysaccharide (LPS) sensitization via upregulation of LPS binding protein in rat. PLoS One (2013) 0.84
Prognostic Value and Daily Trend of Interleukin-6, Neutrophil CD64 Expression, C-Reactive Protein and Lipopolysaccharide-Binding Protein in Critically Ill Patients: Reliable Predictors of Outcome or Not? J Med Biochem (2015) 0.82
Markers for sepsis diagnosis in the forensic setting: state of the art. Croat Med J (2014) 0.82
CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin. PLoS One (2013) 0.82
Biomarkers of sepsis: lost in translation? Crit Care Med (2008) 0.82
Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care (2017) 0.82
Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology. Int J Legal Med (2012) 0.79
Postmortem chemistry update part II. Int J Legal Med (2011) 0.78
Diagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Clinical Significance of Molecular Diagnostic Tools for Bacterial Bloodstream Infections: A Systematic Review. Interdiscip Perspect Infect Dis (2016) 0.75
Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis. Springerplus (2016) 0.75
Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One (2017) 0.75
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Sepsis in European intensive care units: results of the SOAP study. Crit Care Med (2006) 11.78
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Anemia and blood transfusion in critically ill patients. JAMA (2002) 7.83
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*. Crit Care Med (2013) 5.88
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA (2003) 4.54
Prognostic value of extravascular lung water in critically ill patients. Chest (2002) 4.46
A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care (2008) 4.31
High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest (2005) 3.58
Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med (2015) 3.55
The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med (2013) 3.43
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30
Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003. Intensive Care Med (2004) 3.16
Current practice in nutritional support and its association with mortality in septic patients--results from a national, prospective, multicenter study. Crit Care Med (2008) 3.12
Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med (2007) 2.97
Challenges in end-of-life care in the ICU: statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003: executive summary. Crit Care Med (2004) 2.95
Biomarkers of sepsis. Crit Care Med (2009) 2.88
Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med (2005) 2.73
A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med (2009) 2.60
Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med (2006) 2.47
Practice and perception--a nationwide survey of therapy habits in sepsis. Crit Care Med (2008) 2.43
High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med (2003) 2.43
Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med (2011) 2.30
Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med (2008) 2.27
Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant (2007) 2.25
The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg (2010) 2.23
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12
Attributable costs of patients with candidemia and potential implications of polymerase chain reaction-based pathogen detection on antifungal therapy in patients with sepsis. J Crit Care (2012) 2.11
Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med (2010) 2.08
Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med (2003) 2.01
An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study. Intensive Care Med (2006) 2.00
A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg (2011) 2.00
Fluid replacement with hydroxyethyl starch in critical care--a reassessment. Dtsch Arztebl Int (2013) 1.87
Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med (2013) 1.85
Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock (2009) 1.82
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med (2004) 1.80
The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care (2011) 1.77
Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care (2008) 1.76
Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med (2012) 1.71
Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med (2011) 1.66
Hospital Incidence and Mortality Rates of Sepsis. Dtsch Arztebl Int (2016) 1.65
Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med (2002) 1.55
The importance of religious affiliation and culture on end-of-life decisions in European intensive care units. Intensive Care Med (2007) 1.52
Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury. J Crit Care (2008) 1.43
The world's major religions' points of view on end-of-life decisions in the intensive care unit. Intensive Care Med (2007) 1.43
Venous oximetry. Curr Opin Crit Care (2006) 1.41
Stop sepsis-save lives: A call to join the global coalition for the World Sepsis Day. J Crit Care (2012) 1.38
Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock (2002) 1.35
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest (2002) 1.28
Communication of end-of-life decisions in European intensive care units. Intensive Care Med (2005) 1.28
The obesity paradox in surgical intensive care unit patients. Intensive Care Med (2011) 1.27
Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis. Crit Care (2014) 1.26
Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care (2005) 1.24
Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care (2006) 1.23
Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care (2009) 1.23
The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care (2009) 1.22
Readmission to a surgical intensive care unit: incidence, outcome and risk factors. Crit Care (2008) 1.20
Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PLoS One (2012) 1.12
Low and "supranormal" central venous oxygen saturation and markers of tissue hypoxia in cardiac surgery patients: a prospective observational study. Intensive Care Med (2010) 1.10
Epidemiology of and factors associated with end-of-life decisions in a surgical intensive care unit. Crit Care Med (2010) 1.10
Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care (2011) 1.09
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care (2010) 1.09
Safety of modern starches used during surgery: misleading conclusions. Anesth Analg (2013) 1.08
Anemia and blood transfusion in a surgical intensive care unit. Crit Care (2010) 1.06
Family satisfaction in the intensive care unit: a quantitative and qualitative analysis. Intensive Care Med (2013) 1.06
Venous oximetry. Intensive Care Med (2005) 1.06
Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica (2008) 1.04
Extracranial complications in patients with acute brain injury: a post-hoc analysis of the SOAP study. Intensive Care Med (2008) 1.03
Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care (2014) 1.00
Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med (2002) 0.99
Molecular diagnostics of sepsis--where are we today? Int J Med Microbiol (2010) 0.99
Use of the pulmonary artery catheter is not associated with worse outcome in the ICU. Chest (2005) 0.99
Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost (2009) 0.98
Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated). Crit Care (2008) 0.97
The protein C pathway: implications for the design of the RESPOND study. Crit Care (2007) 0.96
The burden of sepsis-a call to action in support of World Sepsis Day 2013. J Crit Care (2013) 0.96
Platelet-derived microvesicles induce differential gene expression in monocytic cells: a DNA microarray study. Platelets (2006) 0.96
The PIRO concept: R is for response. Crit Care (2003) 0.94
CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients. Crit Care (2012) 0.93
CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients. Intensive Care Med (2009) 0.92
Early- versus late-onset shock in European intensive care units. Shock (2007) 0.92
Sepsis and organ system failure are major determinants of post-intensive care unit mortality. J Crit Care (2008) 0.91
Tight glucose control and hypoglycemia. Crit Care Med (2008) 0.91
Neutrophil stimulation with granulocyte colony-stimulating factor worsens ventilator-induced lung injury and mortality in rats. Anesthesiology (2005) 0.90
HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care (2009) 0.90
Serial measurement of Therapeutic Intervention Scoring System-28 (TISS-28) in a surgical intensive care unit. J Crit Care (2010) 0.90